These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12176605)

  • 21. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation.
    Brunner-La Rocca HP; Kiowski W
    Transplantation; 1998 Feb; 65(4):533-8. PubMed ID: 9500629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transvenous lung biopsy: a new technique.
    Hakim M; Stovin P; English T; Wallwork J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2573. PubMed ID: 3274566
    [No Abstract]   [Full Text] [Related]  

  • 25. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation.
    Kesten S; Chamberlain D; Maurer J
    J Heart Lung Transplant; 1996 Apr; 15(4):384-8. PubMed ID: 8732597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Special problems after lung transplantation: walking a tightrope between infection and graft rejection].
    Gaspert A; Boehler A; Weder W; Speich R; Vogt P
    Schweiz Med Wochenschr; 2000 Jun; 130(25):944-51. PubMed ID: 10909721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of QT dispersion analysis for noninvasive detection of cardiac allograft rejection.
    Regueiro-Abel M; Crespo-Leiro MG; Muñiz J; Gonzalez-Juanatey JR; Paniagua MJ; Rodriguez JA; Vazquez-Rodriguez JM; Juffe A; Castro-Beiras A
    Transplant Proc; 2002 Feb; 34(1):168-70. PubMed ID: 11959234
    [No Abstract]   [Full Text] [Related]  

  • 28. MRI investigations of graft rejection following organ transplantation using rodent models.
    Wu YJ; Sato K; Ye Q; Ho C
    Methods Enzymol; 2004; 386():73-105. PubMed ID: 15120247
    [No Abstract]   [Full Text] [Related]  

  • 29. The pathologic changes in long-term heart and lung transplant survivors.
    Billingham ME
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S252-7. PubMed ID: 1387551
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and electrophysiological characteristics of vascular rejection after cardiac transplantation.
    Weyand M; Konertz W; Fahrenkamp A; Torp U; Bernhard A; Scheld HH
    Transplant Proc; 1992 Oct; 24(5):2009-10. PubMed ID: 1412951
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children.
    Zales VR; Crawford S; Backer CL; Pahl E; Webb CL; Lynch P; Mavroudis C; Benson DW
    J Am Coll Cardiol; 1994 Mar; 23(3):766-71. PubMed ID: 8113563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Noninvasive methods for the diagnosis of rejection after heart transplantation].
    Belgi A; Başarici I
    Anadolu Kardiyol Derg; 2003 Sep; 3(3):245-51. PubMed ID: 12967893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasculitides and eosinophils in endomyocardial biopsies as rejection predictors in heart transplantation.
    Cipullo R; Finger MA; Rossi Neto JM; Contreras CM; Poltronieri NV; Zamorano Mde M; Silva LM; Chaccur P; Dinkhuysen JJ; Stolf NA
    Arq Bras Cardiol; 2011 Aug; 97(2):163-70. PubMed ID: 21655876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation.
    Chin C; Akhtar MJ; Rosenthal DN; Bernstein D
    J Pediatr; 2000 Feb; 136(2):238-42. PubMed ID: 10657832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive cardiac allograft monitoring.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Schreier G; Tscheliessnigg KH
    Transplant Proc; 2001 Jun; 33(4):2456-7. PubMed ID: 11406210
    [No Abstract]   [Full Text] [Related]  

  • 36. Endothelial adhesion molecules in human heart and lung transplants.
    Steinhoff G; Behrend M; Richter N; Haverich A
    Transplant Proc; 1995 Feb; 27(1):1274-6. PubMed ID: 7533378
    [No Abstract]   [Full Text] [Related]  

  • 37. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.
    Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G
    J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telemetric system for ambulatory lung function analysis in transplanted patients.
    Ewert R; Wensel R; Müller J; Hetzer R
    Transplant Proc; 2000 Feb; 32(1):204-5. PubMed ID: 10701025
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
    Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
    J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.